SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.49+1.6%11:35 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Lamb who wrote (6984)2/10/1999 10:50:00 PM
From: Gunther G. Smith  Read Replies (2) of 9523
 
CELEBREX will be a smash hit for PFE. It is already ranked the second most successful pharmaceutical launch (behind VIAGRA) in history. It has the potential to eat every other NSAID's lunch on the market because of its advanced safety profile (ie, no more gastric ulcers and no adverse effects on hemostasis (bleeding time and platelet aggregation) for people who must take pain relievers chronically. Plus the stuff really works at least as well as any other NSAID on the market.

Here's my question to folks on this thread: Does anyone know when PFE might split again?

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext